Steven K. Libutti

21.6k citations

331 papers · 15.2k indexed · 3 hit papers · h-index 67

Impact in

Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies

Papers in

Oncology 111
- Pancreatic and Hepatic Oncology Research 45
- Lung Cancer Research Studies 27
Nephrology 25
- Parathyroid Disorders and Treatments 25

Co-authors: H. Richard Alexander McClellan M. Walther Peter L. Choyke David L. Bartlett Andrew L. Feldman G.M. Glenn W. Marston Linehan Edward H. Oldfield
Journals: Surgery (30 papers)Annals of Surgical Oncology (19 papers)Journal of Clinical Oncology (13 papers)Cancer (12 papers)Journal of the American College of Surgeons (9 papers)
Partner nations: United States Canada Switzerland

In The Last Decade

Steven K. Libutti

325 papers receiving 14.8k citations

Hit Papers

align trajectories log scale

The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors 2019 · 234 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Pancreas
2010 Clinical Cancer Research
2003 The Lancet

Peers

Countries citing papers authored by Steven K. Libutti

Since Specialization

Citations

This map shows the geographic impact of Steven K. Libutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven K. Libutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven K. Libutti more than expected).

Fields of papers citing papers by Steven K. Libutti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven K. Libutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven K. Libutti. The network helps show where Steven K. Libutti may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven K. Libutti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven K. Libutti Line = papers co-authored together Steven K. Libutti links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rutgers Cancer Institute of New Jersey's Community Outreach and Engagement Approach to Cancer Prevention Cancer Prevention Research ·Anita Y. Kinney, Antoinette M. Stroup, W. J. George, Steven K. Libutti	2023	1
2	Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis Cancer Research Communications ·Mijung Kwon, J. MacKenty, Haitao Wang, Gregory Riedlinger, Asha Adem, H. Zhong, Abhishek Bharti, Kazuo Sugihara, 李鸿雁, David S. Schrump, Sharon R. Pine, Steven K. Libutti	2022	8
3	Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection Molecular Biology and Evolution ·Christopher Markosian, Daniela I. Staquicini, Prashant Dogra, Da Silva M, Joseph H. Lubin, 木全央幸, Tracey L. Smith, Vinícius G. Contessoto, Steven K. Libutti, Zhihui Wang, Vittorio Cristini, Sagar D. Khare, Paul C. Whitford, S.K. Burley, José N. Onuchic, Renata Pasqualini, Wadih Arap	2022	5
4	FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1 Cancer Research ·Mijung Kwon, J. MacKenty, Nicholas Nolan, Tyler Self, A. A. Saltykova, Asha Adem, M Allou, Zhongren Zhou, Michael P. Verzi, Sharon R. Pine, Steven K. Libutti	2021	10
5	Comparison of Bethesda cytopathology classification to surgical pathology across racial‐ethnic groups Head & Neck ·Christopher M. Jeanfreau, Vikas Mehta, Bradley A. Schiff, Richard V. Smith, Samer Khader, Valentina Vallenari, Juan Lin, Steven K. Libutti, Amanda M. Laird, Thomas J. Ow	2019	4
6	Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association HPB ·John C. Mansour, Kenneth D. Chavin, Gareth Morris‐Stiff, Susanne G. Warner, Kenneth Cardona, Zhi Ven Fong, Ajay V. Maker, Steven K. Libutti, Robert S. Warren, Charles R. St. Hill, Scott Celinski, Philippa Newell, Quan P. Ly, James R. Howe, Natalie G. Coburn	2018	19
7	Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma Surgery ·H. Richard Alexander, David L. Bartlett, James F. Pingpank, Steven K. Libutti, Richard E. Royal, Marybeth S. Hughes, Matthew P. Holtzman, Nader Hanna, Keli Turner, Tatiana Beresneva, Yue Zhu	2013	105
8	Downregulation of Filamin A Interacting Protein 1-Like is Associated with Promoter Methylation and Induces an Invasive Phenotype in Ovarian Cancer Molecular Cancer Research ·P. Komninou, Tony Williams, Soojin Lee, Pignatti Pf, Kathleen D. Whitney, Joon‐Yong Chung, Stephen M. Hewitt, Gloria S. Huang, Gary L. Goldberg, Steven K. Libutti, Mijung Kwon	2011	26
9	Strategies for Targeting Tumors and Tumor Vasculature for Cancer Therapy Advances in genetics ·周理斌, Steven K. Libutti	2010	13
10	Expression Signature Developed from a Complex Series of Mouse Models Accurately Predicts Human Breast Cancer Survival Clinical Cancer Research ·Mei He, David P. Mangiameli, Stefan S. Kachala, Kent W. Hunter, John W. Gillespie, Xiaopeng Bian, Hui Shen, Steven K. Libutti	2009	17
11	Recapitulation of Pancreatic Neuroendocrine Tumors in Human Multiple Endocrine Neoplasia Type I Syndrome via Pdx1 -Directed Inactivation of Men1 Cancer Research ·Hui Shen, Mei He, Anathea C. Powell, Asha Adem, Dominique Lorang, Johan Hasselberg, Amelia Grover, Kris Ylaya, Stephen M. Hewitt, Stephen J. Marx, Allen M. Spiegel, Steven K. Libutti	2009	60
12	Multiple Endocrine Neoplasia Type 1: Clinical Manifestations and Management Cancer treatment and research ·Anathea C. Powell, Steven K. Libutti	2009	12
13	Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature PLoS ONE ·Melissa Paoloni, Anita Tandle, Christina Mazcko, Carlos Guevara-Serra, Stefan S. Kachala, Amy K. LeBlanc, Shelley J. Newman, David M. Vail, Carolyn J. Henry, Douglas H. Thamm, Karin U. Sørenmo, Amin Hajitou, Renata Pasqualini, Wadih Arap, Chand Khanna, Steven K. Libutti	2009	88
14	Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors Clinical Cancer Research ·Nijaguna B. Prasad, Helina Somervell, Ralph P. Tufano, Alan P.B. Dackiw, Michael R. Marohn, Joseph A. Califano, Yongchun Wang, William H. Westra, Douglas P. Clark, Christopher B. Umbricht, Steven K. Libutti, Martha A. Zeiger	2008	66
15	A Subset of Host B Lymphocytes Controls Melanoma Metastasis through a Melanoma Cell Adhesion Molecule/MUC18-Dependent Interaction: Evidence from Mice and Humans Cancer Research ·Fernanda I. Staquicini, Anita Tandle, Steven K. Libutti, Jessica D. Sun, Maya Zigler, Menashe Bar‐Eli, Jayshree Sarma, Elizabeth Cristina Pérez, Jeffrey E. Gershenwald, Mário Mariano, Renata Pasqualini, Wadih Arap, José Daniel Lopes	2008	59
16	A novel PDE4 inhibitory agent with endothelial cell specific activity. Cancer Research ·Jennifer E. Rosen, 珠材酒井, Mei He, Wu Xing an, H. Richard Alexander, Faribourz Payvandi, David Stirling, Peter Schäfer, Steven K. Libutti	2004	1
17	A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay Journal of Translational Medicine ·珠材酒井, Mark L. Kayton, Sņežana Lukša, Wu Xing an, Mei He, JEREMY FREESE, Galina Baibakov, Dominique Lorang, Vladimir Knežević, Elise C. Kohn, H. Richard Alexander, David Stirling, Faribourz Payvandi, George W. Muller, Steven K. Libutti	2004	29
18	Role of metastasectomy in the management of thyroid carcinoma: The NIH experience Journal of Surgical Oncology ·Nwidu LL, Loukas Gourgiotis, Nancy E. Walker, Lori C. Guthrie, Monica C. Skarulis, James C. Reynolds, Maria J. Merino, David S. Schrump, Steven K. Libutti, H. Richard Alexander, Nicholas J. Sarlis	2002	35
19	Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of a thymidine kinase-deleted mutant Cancer Gene Therapy ·Markus Puhlmann, Charles K. Brown, Michael Gnant, James Huang, Steven K. Libutti, H. Richard Alexander, David L. Bartlett	2000	128
20	Multiple Neuroendocrine Tumors of the Pancreas in von Hippel-Lindau Disease Patients American Journal Of Pathology ·Irina A. Lubensky, Svetlana Pack, M Deepesh, Alexander O. Vortmeyer, Steven K. Libutti, Peter L. Choyke, McClellan M. Walther, W. Marston Linehan, Zhengping Zhuang	1998	183

About Steven K. Libutti

Steven K. Libutti is a scholar working on Oncology, Nephrology, Neurology, Cancer Research and Hepatology, having authored 331 papers that have together received 15.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (87 papers), Neuroblastoma Research and Treatments (45 papers), Pancreatic and Hepatic Oncology Research (45 papers), Angiogenesis and VEGF in Cancer (36 papers), Lung Cancer Research Studies (27 papers), Cancer, Hypoxia, and Metabolism (25 papers), Parathyroid Disorders and Treatments (25 papers) and Hepatocellular Carcinoma Treatment and Prognosis (22 papers). The work is most often cited by research in Cancer Research (2.7k citations), Oncology (4.7k citations), Neurology (1.9k citations), Nephrology (868 citations) and Epidemiology (3.2k citations). Steven K. Libutti has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include H. Richard Alexander, McClellan M. Walther, Peter L. Choyke, David L. Bartlett, Andrew L. Feldman, G.M. Glenn, W. Marston Linehan, Edward H. Oldfield, Emily Y. Chew and Russell R. Lonser. Their work appears in journals such as Surgery, Annals of Surgical Oncology, Journal of Clinical Oncology, Cancer and Journal of the American College of Surgeons.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact